NEW MEXICO EDUCATIONAL RETIREMENT BOARD - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 286 filers reported holding HAEMONETICS CORP in Q2 2020. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW MEXICO EDUCATIONAL RETIREMENT BOARD ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$923
+5.2%
10,3000.0%0.04%
+2.6%
Q2 2023$877
+15.2%
10,300
+12.0%
0.04%
+2.6%
Q1 2023$761
+21.0%
9,200
+15.0%
0.04%
+11.8%
Q4 2022$629
-99.9%
8,0000.0%0.03%
+6.2%
Q3 2022$592,000
+13.6%
8,0000.0%0.03%
+28.0%
Q2 2022$521,000
-21.5%
8,000
-23.8%
0.02%0.0%
Q1 2022$664,000
+19.2%
10,5000.0%0.02%
+31.6%
Q4 2021$557,000
-24.8%
10,5000.0%0.02%
-26.9%
Q3 2021$741,000
+5.9%
10,5000.0%0.03%
+8.3%
Q2 2021$700,000
-29.1%
10,500
+18.0%
0.02%
-38.5%
Q1 2021$988,000
-6.5%
8,9000.0%0.04%
-13.3%
Q4 2020$1,057,000
+16.5%
8,900
-14.4%
0.04%
+4.7%
Q3 2020$907,000
-16.3%
10,400
-14.0%
0.04%
-15.7%
Q2 2020$1,084,000
-10.1%
12,1000.0%0.05%
-30.1%
Q1 2020$1,206,000
+19.3%
12,100
+37.5%
0.07%
+73.8%
Q4 2019$1,011,000
-8.9%
8,8000.0%0.04%
-16.0%
Q3 2019$1,110,000
+4.8%
8,8000.0%0.05%
+8.7%
Q2 2019$1,059,000
+15.2%
8,800
-16.2%
0.05%
+17.9%
Q1 2019$919,000
-12.6%
10,5000.0%0.04%
-22.0%
Q4 2018$1,051,000
-24.8%
10,500
-13.9%
0.05%
-5.7%
Q3 2018$1,398,000
+27.8%
12,2000.0%0.05%
+23.3%
Q2 2018$1,094,00012,2000.04%
Other shareholders
HAEMONETICS CORP shareholders Q2 2020
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders